Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × bemarituzumab × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Oxaliplatin 16 Fluorouracil 15 pembrolizumab 11 Capecitabine 11 Leucovorin 10 Nivolumab 9 Trastuzumab 6 Specimen Handling 6 Cisplatin 6 trastuzumab deruxtecan 5 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Biopsy 4 zimberelimab 3 Folfox protocol 3 Drug Therapy 3 Docetaxel 3 Bevacizumab 3 zanidatamab 2 tucatinib 2 trifluridine tipiracil drug combination 2 durvalumab 2 XELOX 2 zolbetuximab 1 toripalimab 1 tislelizumab 1 talazoparib 1 ropidoxuridine 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05052801 2026-02-19

FORTITUDE-101

Amgen

Phase 3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡